Financing Round Led by Questa Capital to Fuel Commercialization of ControlRad Trace Mobile C-arm Radiation Reduction Technology Medical Device Industry Veterans Ryan Drant and Tim Patrick Join Board
ControlRad™ Announces FDA Clearance and Launch of the Only Radiation Reduction Technology that Integrates into Mobile C-arms
The ControlRad Trace solution reduces unnecessary radiation up to 89%, protecting patients and medical staff without compromising image quality or workflow. 1
Innovative implant from Nvision corrects hammertoe, and expands product offering to lower extremities
With over 25 years of leadership experience, Chris will have an immediate impact as ControlRad prepares to launch its dramatic radiation dose reduction solutions.
David Shulkin’s experience in running healthcare systems makes the appointment a strategic addition as ControlRad moves into a commercial phase.